Alagille M, Blondiaux I, Ginestet D
Service de Psychiatrie, Hôpital Paul Brousse, Villejuif.
Encephale. 1990 Mar-Apr;16(2):125-31.
Neuroleptic maintenance treatment in schizophrenia is a conflicting issue. There is no reliable criteria to identify patients for which neuroleptic withdrawal can be experienced. However, treatment discontinuation, whose risks can be limited, must be attempted for reasons such as the patient's wellbeing, longterm side-effects prevention and patient-doctor relationship management. Anyway, it can lead to more specific indications for drug maintenance.